Skip to main content

Table 2 Characteristics of the RADAR-AD study cohort

From: RADAR-AD: assessment of multiple remote monitoring technologies for early detection of Alzheimer’s disease

  

HC

PreAD

ProAD

MildAD

Overall

a) Cohort-specific

N

69

39

65

56

229

Female

55.1 %

59.0 %

41.5 %

44.6 %

49.3 %

Age

67.3 (7.5)

70.7 (5.8)

69.7 (7.7)

70.0 (8.9)

69.2 (7.7)

Education Years

14.5 (3.6)

15.6 (2.8)

14.6 (4.6)

13.7 (4.2)

14.5 (4.0)

BMI

25.7 (3.1)

24.6 (3.9)

25.1 (3.6)

24.0 (3.6)

24.9 (3.6)

APOE E4 statusa

13/4/52

6/14/19

11/24/30

5/25/26

35/67/127

CDR

0.0 (0.0)

0.0 (0.1)

0.5 (0.1)

1.1 (0.4)

0.4 (0.5)

CDR Range

0.0

0.0–0.5

0–0.5

0.5–2.0

0.0–2.0

MMSE

29.2 (0.9)

29.1 (1.0)

26.5 (2.3)

21.7 (3.3)

26.6 (3.7)

MMSE Range

27–30

26–30

19–30

16–29

16–30

A-iADL

68.2 (2.6)

66.1 (3.9)

58.6 (7.1)

46.8 (8.0)

59.8 (10.2)

b) RMT-specific

Altoida

57

28

38

12

135

Axivity

60

32

56

44

192

Banking

62

34

57

50

203

Fitbit

68

39

56

52

215

Mezurio

66

27

44

26

163

Physilog (Dual)

56

31

49

40

176

Physilog (TUG)

52

31

47

38

168

iADL

67

37

63

55

222

  1. Shown are the characteristics of the study groups Healthy Control (HC), Preclinical AD (PreAD), Prodromal AD (ProAD), and Mild-to-Moderate AD (MildAD), as well as the overall study cohort. a) Descriptive statistics per group, including mean values and standard deviation (where applicable), the number of participants carrying or not carrying APOE E4 alleles, and MMSE and CDR ranges.. b) Number of participants for which RMT/Questionnaire data was obtained
  2. aOrder: participants without APOE E4 alleles, participants with APOE E4 alleles, participants with unknown APOE E4 status